Ziwei Bao

Suzhou, 215000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Analysis of Adverse Drug Reactions of Clofazimine Reported in the FDA Adverse Event Reporting System from 2004 to 2025 Q1.

Analysis of Adverse Drug Reactions of Clofazimine Reported in the FDA Adverse Event Reporting System from 2004 to 2025 Q1.

Journal: Infectious diseases and therapy

Published: July 15, 2025

Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis.

Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis.

Journal: Pharmaceutics

Published: September 07, 2023

The diagnostic performance of GeneXpert MTB/RIF in tuberculosis meningitis: A multicentre accuracy study.

The diagnostic performance of GeneXpert MTB/RIF in tuberculosis meningitis: A multicentre accuracy study.

Journal: Diagnostic microbiology and infectious disease

Published: July 21, 2023

Acquired drug resistance during the turnaround time for drug susceptibility testing impacts outcome of tuberculosis.

Acquired drug resistance during the turnaround time for drug susceptibility testing impacts outcome of tuberculosis.

Journal: Tuberculosis (Edinburgh, Scotland)

Published: October 30, 2022

Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients.

Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients.

Journal: Frontiers in pharmacology

Published: August 18, 2022

Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China.

Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China.

Journal: The European respiratory journal

Published: July 09, 2021

Additional drug resistance for Mycobacterium tuberculosis during turnaround time for drug-susceptibility testing in China: A multicenter observational cohort study.

Additional drug resistance for Mycobacterium tuberculosis during turnaround time for drug-susceptibility testing in China: A multicenter observational cohort study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: January 21, 2021

Drug Exposure and Minimum Inhibitory Concentration Predict Pulmonary Tuberculosis Treatment Response.

Drug Exposure and Minimum Inhibitory Concentration Predict Pulmonary Tuberculosis Treatment Response.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 03, 2020

Drug exposure of first-line anti-tuberculosis drugs in China: A prospective pharmacological cohort study.

Drug exposure of first-line anti-tuberculosis drugs in China: A prospective pharmacological cohort study.

Journal: British journal of clinical pharmacology

Published: November 29, 2019

Showing 1-9 of 9

Last Updated: 09/26/2026